117 related articles for article (PubMed ID: 1408146)
1. Altered H1 histamine receptor signaling in Balb/3T3 cells transformed by v-K-ras and v-H-ras oncogenes.
Blackmore PF; Oakes SG; Somers KD
Oncogene; 1992 Oct; 7(10):2053-7. PubMed ID: 1408146
[TBL] [Abstract][Full Text] [Related]
2. Pharmacology of [3H]-pyrilamine binding and of the histamine-induced inositol phosphates generation, intracellular Ca2+ -mobilization and cytokine release from human corneal epithelial cells.
Sharif NA; Wiernas TK; Griffin BW; Davis TL
Br J Pharmacol; 1998 Nov; 125(6):1336-44. PubMed ID: 9863665
[TBL] [Abstract][Full Text] [Related]
3. Alpha 1-adrenergic and H1-histamine receptor control of intracellular Ca2+ in a muscle cell line: the influence of prior agonist exposure on receptor responsiveness.
Brown RD; Prendiville P; Cain C
Mol Pharmacol; 1986 Jun; 29(6):531-9. PubMed ID: 2872587
[TBL] [Abstract][Full Text] [Related]
4. Regulation of epidermal growth factor receptor by activated H-ras and V-myc oncogenes in mouse Balb/3T3 cells: possible roles of AP-1.
Okimoto T; Kohno K; Kuwano M; Gopas J; Kung HF; Ono M
Oncogene; 1996 Apr; 12(8):1625-33. PubMed ID: 8622882
[TBL] [Abstract][Full Text] [Related]
5. Effect of cellular density and viral oncogenes on the major histocompatibility complex class I antigen response to gamma-interferon in BALB-c/3T3 cells.
Offermann MK; Faller DV
Cancer Res; 1990 Feb; 50(3):601-5. PubMed ID: 2105158
[TBL] [Abstract][Full Text] [Related]
6. SCH 51344 inhibits ras transformation by a novel mechanism.
Kumar CC; Prorock-Rogers C; Kelly J; Dong Z; Lin JJ; Armstrong L; Kung HF; Weber MJ; Afonso A
Cancer Res; 1995 Nov; 55(21):5106-17. PubMed ID: 7585559
[TBL] [Abstract][Full Text] [Related]
7. Histamine H1 receptor-mediated Ca2+ signaling in cultured bovine corneal endothelial cells.
Crawford KM; MacCallum DK; Ernst SA
Invest Ophthalmol Vis Sci; 1992 Oct; 33(11):3041-9. PubMed ID: 1356944
[TBL] [Abstract][Full Text] [Related]
8. Coexistence of histamine H1 and H2 receptors coupled to distinct signal transduction pathways in isolated intestinal muscle cells.
Morini G; Kuemmerle JF; Impicciatore M; Grider JR; Makhlouf GM
J Pharmacol Exp Ther; 1993 Feb; 264(2):598-603. PubMed ID: 8382277
[TBL] [Abstract][Full Text] [Related]
9. A role for Ras in v-Crk transformation.
Greulich H; Hanafusa H
Cell Growth Differ; 1996 Nov; 7(11):1443-51. PubMed ID: 8930393
[TBL] [Abstract][Full Text] [Related]
10. Resistance to apoptosis induced by alkylating agents in v-Ha-ras-transformed cells due to defect in p53 function.
Kuo ML; Chou YW; Chau YP; Huang TS
Mol Carcinog; 1997 Apr; 18(4):221-31. PubMed ID: 9142217
[TBL] [Abstract][Full Text] [Related]
11. trans-Dominant suppressor mutations of the H-ras oncogene.
Ogiso Y; Gutierrez L; Wrathall LS; Lu YY; Blair DG; Clanton DJ; Hwang YW; Shih TY
Cell Growth Differ; 1990 May; 1(5):217-24. PubMed ID: 2150753
[TBL] [Abstract][Full Text] [Related]
12. Histamine modulates contraction and cyclic nucleotides in cultured rat mesangial cells. Differential effects mediated by histamine H1 and H2 receptors.
Sedor JR; Abboud HE
J Clin Invest; 1985 May; 75(5):1679-89. PubMed ID: 2582001
[TBL] [Abstract][Full Text] [Related]
13. Histamine stimulates glycogen breakdown and increases 45Ca2+ permeability in rat astrocytes in primary culture.
Arbonés L; Picatoste F; García A
Mol Pharmacol; 1990 Jun; 37(6):921-7. PubMed ID: 2163018
[TBL] [Abstract][Full Text] [Related]
14. Regulation of bradykinin B2 receptors by the ras oncogene: evidence for multiple mechanisms.
Hembree TN; Leeb-Lundberg LM
J Cell Physiol; 1996 Nov; 169(2):248-55. PubMed ID: 8908192
[TBL] [Abstract][Full Text] [Related]
15. Involvement of histamine H1 and H2 receptors in the regulation of STAT-1 phosphorylation: inverse agonism exhibited by the receptor antagonists.
Sakhalkar SP; Patterson EB; Khan MM
Int Immunopharmacol; 2005 Jul; 5(7-8):1299-309. PubMed ID: 15914334
[TBL] [Abstract][Full Text] [Related]
16. The cell biology of ras-induced transformation: insights from studies utilizing an inducible hybrid oncogene system.
Haliotis T; Trimble W; Chow S; Mills G; Girard P; Kuo JF; Govindji N; Hozumi N
Anticancer Res; 1988; 8(5A):935-45. PubMed ID: 2845854
[TBL] [Abstract][Full Text] [Related]
17. Recessive (mediator-) revertants from c-H-ras oncogene-transformed NIH 3T3 cells: tumorigenicity in nude mice and transient anchorage and serum independence of the recovered tumor cells in culture.
Omata-Yamada T; Yamada H; Lengyel P
J Cell Physiol; 1991 Nov; 149(2):214-21. PubMed ID: 1748716
[TBL] [Abstract][Full Text] [Related]
18. H1-histamine receptors on human astrocytoma cells.
Nakahata N; Martin MW; Hughes AR; Hepler JR; Harden TK
Mol Pharmacol; 1986 Feb; 29(2):188-95. PubMed ID: 2419744
[TBL] [Abstract][Full Text] [Related]
19. Modulation of bradykinin-induced intracellular Ca2+ oscillations in v-Ki-ras-transformed fibroblasts.
Fu T; Gu ZL; Xu YH
Zhongguo Yao Li Xue Bao; 1994 Nov; 15(6):511-5. PubMed ID: 7709749
[TBL] [Abstract][Full Text] [Related]
20. EGF receptor activity and mitogenic response of Balb/3T3 cells expressing Ras and Myc oncogenes. EGF receptor activity in oncogene transformed cells.
Gopas J; Ono M; Princler G; Smith MR; Tainsky MA; Siddiqui MA; Wishniak O; Segal S; Kuwano M; Kung HF
Cell Mol Biol; 1992 Sep; 38(6):605-14. PubMed ID: 1303308
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
